Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New study proposes public health guidelines to reduce the harms from cannabis use

23.09.2011
The most reliable way to avoid cannabis-related harms is to abstain from use

A new research study conducted by an international team of experts recommends a public health approach to cannabis - including evidence-based guidelines for lower-risk use - to reduce the health harms that result from the use of cannabis.

Led by CAMH scientist and CIHR/PHAC* Chair in Applied Public Health (Simon Fraser University, Vancouver) Dr. Benedikt Fischer, the study is being published in the September/October 2011 issue of the Canadian Journal of Public Health (CJPH).

More than one in ten Canadian adults, and about one in three young people aged 16-25, report using cannabis during the past year. Despite the prevalence and health risks associated with cannabis use, the study points out that Canada has not yet taken a public health approach to address its harms, as we have with alcohol, tobacco, and even injection drug use.

"A broad-based public health approach to cannabis use would include a prevention strategy for young people, risk reduction strategies for at-risk users, and better access to treatment for problem users," explains Dr. Fischer. His latest study addresses the risk reduction component, based on a comprehensive review of existent scientific data identifying the preeminent cannabis use patterns and practices leading to key health risks and harms. Based on this evidence, guidelines are offered on how to modify these practices and patterns at the user-level as a public health-oriented policy tool to reduce the harms.

"Misinformation about cannabis can be dangerous," Dr. Fischer explained. For example, surveys show that many young cannabis users believe that it is safe to drive after using cannabis, whereas recent research in Canada shows that a significant number of traffic fatalities in young adults are attributable to cannabis use. "This resembles the situation forty years ago, when the majority of Canadians still believed it was safe to drink and drive," said Dr. Fischer.

"Cannabis is not a benign drug." Dr. Fischer continued. "The evidence linking patterns of use and problems is strong. We can use this evidence to provide straightforward, factual information to cannabis users and their families, friends or peers, on how to reduce the risks for problems, and to create screening tools for health professionals to help address the risks."

Some of the harmful practices and patterns of use documented in the study include:

Cannabis use at a young age – Longitudinal studies suggest that using cannabis from a young age can be associated with a number of problems, including mental illness and dependence. While most cannabis users will not progress to other illicit substance use, those who use cannabis from a young age are far more likely to make this transition.

Frequent use - Using cannabis often, usually defined as daily or near-daily use, has been linked to a variety of health problems, including cognitive and memory performance, or risk for dependence.

Cannabis use before driving - Recent data suggests that approximately five percent of Canadian adult drivers report driving after cannabis use in the past year, and high school student surveys show that more students drive after cannabis use than after drinking alcohol. It is recommended that anyone using cannabis should not drive for three to four hours after consumption.

Cannabis use during pregnancy - While the possible consequences of cannabis use during pregnancy have not been reliably distinguished from the potentially confounding impact of alcohol and tobacco use, there is sufficient scientific basis to recommend abstinence from cannabis use during pregnancy.

"A key message is that the most reliable way to avoid cannabis-related harms is to abstain from use," said Dr. Fischer. "Those who do use cannabis need to be advised about patterns of use to avoid problems in the short and long run. Our guidelines are meant to target the most dangerous patterns of use among those citizens who use cannabis, and therefore reduce the possible health problem consequences of such use."

Using scientific evidence to provide guidelines on practices or patterns of use that substantially reduce the risks of acute and long-term harms is analogous to the 'Low Risk Drinking Guidelines' for alcohol, which were first introduced in the 1990s. "Given the prevalence and age distribution of cannabis use in Canada, a public health approach to cannabis use - including prevention strategies for young people, risk reduction, and access to treatment - is overdue," Dr. Fischer stated.

The Canadian Public Health Association endorses the Lower Risk Cannabis Use Guidelines. "The next step is for health and education authorities and the wider community to begin discussion of the evidence-based guidelines, and how this information could best be conveyed to key target groups in the context of a broad-based public health approach," Dr. Fischer said.

*"CIHR/PHAC" refers to the Canadian Institutes of Health Research/Public Health Agency of Canada

The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health and addiction teaching hospital, as well as one of the world's leading research centres in the area of addiction and mental health. CAMH combines clinical care, research, education, policy development, prevention and health promotion to transform the lives of people affected by mental health and addiction issues.

CAMH is fully affiliated with the University of Toronto, and is a Pan American Health Organization/World Health Organization Collaborating Centre.

Michael Torres | EurekAlert!
Further information:
http://www.camh.net

More articles from Studies and Analyses:

nachricht The personality factor: How to foster the sharing of research data
06.09.2017 | ZBW – Leibniz-Informationszentrum Wirtschaft

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>